Labshake search
Citations for R&D Systems :
301 - 350 of 722 citations for 7 CYANO 4 HYDROXY 3 QUINOLINECARBOXYLIC ACID since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... 0.5 or 3 µg/mL (R&D Systems, Minneapolis, Minnesota, United States) in PBS buffer with 1.5% BSA and 0.025% Tween-20 ...
-
bioRxiv - Cancer Biology 2022Quote: ... and the Human TGF-beta 3 DuoSet ELISA Kit (R&D Systems).
-
bioRxiv - Neuroscience 2022Quote: ... and human NT-3 (10 ng/ml, 267-N3, R&D Systems) for another 20 days.
-
bioRxiv - Immunology 2023Quote: ... were coated with human ICAM-1 (3 μg/mL; R&D system) overnight at 4°C ...
-
bioRxiv - Microbiology 2023Quote: ... Bacteria were treated with either 3 mM recombinant HMGB1 (R&D systems) or buffer in a 50 mL reaction at 37°C for 2 hours ...
-
bioRxiv - Microbiology 2023Quote: ... 3) 50 nM recombinant PolyHistidine-CYLD (R&D systems, Cat# E-556), or 50nM recombinant SdeC DUB (1-192 ...
-
bioRxiv - Bioengineering 2024Quote: ... 3 µm CHIR99021 (Stemgent) and 100 ng/ml SHH (R&D Systems) for 5 days ...
-
bioRxiv - Neuroscience 2021Quote: ... coated plates in N4 media (N3 with 0.05uM Retinoic acid, 2ng/ml BDNF (R&D Systems #248-BDB) and 2 ng/ul GDNF (R&D Systems #212-GD)) ...
-
bioRxiv - Neuroscience 2021Quote: ... offspring at postnatal day 3 to 6 received 7 intraperitoneal injections with either PBS (controls) or 75 ng of carrier free recombinant mouse interleukin-6 (rmIL6, R&D Systems, Minneapolis MN).
-
bioRxiv - Cancer Biology 2020Quote: ... were added to devices with THP-1 M1 macrophages while matrix metalloproteinase 7 (MMP7, clone 111433 at 1 μg/ml) and ANGPT2 (clone 85816 at 1 μg/ml) (all from R&D systems, Minneapolis, MN) neutralizing antibodies were added to devices with THP-1 M2 macrophages ...
-
bioRxiv - Microbiology 2021Quote: ... were cultured for 7 days in RPMI supplemented with 5% decomplemented autologous human blood plasma and 10 ng/mL M-CSF (R&D system, #216-MC) to obtain MDMs ...
-
bioRxiv - Immunology 2022Quote: ... or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems) and alone or in combination of 5 mM Metformin (SIGMA) ...
-
bioRxiv - Cell Biology 2022Quote: ... commercial Sigma-1 R antibody to 3 µg/ml (MAB1076, R&D systems) chicken Calreticulin (Abcam ...
-
bioRxiv - Synthetic Biology 2020Quote: ... 10 ng/mL transforming growth factor beta 3 (TGF-β3, R&D Systems) and 100nM dexamethasone12,27 to make implantable cartilage constructs11 ...
-
bioRxiv - Cancer Biology 2022Quote: ... 3-day old organoids were harvested with Cultrex Harvesting Solution (R&D Systems) and frozen in Recovery Cell Culture Freezing Medium (GIBCO) ...
-
bioRxiv - Immunology 2023Quote: IFN-λ2/3 concentration was determined by commercial sandwich ELISA (R&D Systems) from supernatants infected or not with T ...
-
bioRxiv - Cancer Biology 2023Quote: ... 3-day old organoids were harvested with Cultrex Harvesting Solution (R&D Systems) and frozen in Recovery Cell Culture Freezing Medium (GIBCO) ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197 & 1:100; Biolegend, 125401), anti-Hsp70 (1:300 ...
-
bioRxiv - Neuroscience 2023Quote: ... goat anti-Human DKK-3 (1:1,000, R&D Systems, Cat# AF1118, RRID:AB_354610), rabbit anti-GAPDH (1:5,000 ...
-
bioRxiv - Neuroscience 2023Quote: ... goat anti-Mouse DKK-3 (1:1,000, R&D Systems, Cat# AF948, RRID:AB_355734), goat anti-Human DKK-3 (1:1,000 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Recombinant human galectin 3 binding protein (R&D Systems, and produced in-house), QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) ...
-
bioRxiv - Immunology 2024Quote: ... containing 1 ng/mL IL-3 (R&D Systems in Minneapolis, MN, USA) at 37°C with 5% CO2.
-
bioRxiv - Microbiology 2022Quote: ... IL-4 (R&D Systems Cat#204-IL-050, 20ng/mL), αIgG (Agilent Cat#A042402-2) ...
-
bioRxiv - Immunology 2021Quote: ... 10 ng/mL IL-4 from R&D Systems (404-ML), and 3 μg/mL anti-IFN-γ was added ...
-
bioRxiv - Microbiology 2021Quote: ... 5 ng/mL BMP-4 (314-BP-050, R&D Systems), 50 ng/mL VEGF (293-VE-500 ...
-
bioRxiv - Immunology 2020Quote: ... IL-4 and IL-13 were purchased from R&D Systems. Acid Phosphatase ...
-
bioRxiv - Cancer Biology 2021Quote: Recombinant 52-kDa pro-cath-D (4 µM; R&D Systems) was auto-activated to 51-kDa pseudo-cath-D in 0.1 M Na-acetate buffer (pH 3.5) ...
-
bioRxiv - Biochemistry 2022Quote: ... 20 ng/mL bone morphogenetic protein 4 (BMP4, R&D Systems), and 10 ng/mL fibroblast growth factor-basic (bFGF ...
-
bioRxiv - Developmental Biology 2019Quote: ... 4 ng human recombinant IGF2 (292-G2-050, R&D Systems) was used as positive control ...
-
bioRxiv - Cell Biology 2021Quote: ... 30 ng/ml Bone morphogenic protein-4 (BMP4) (R&D systems), 1.5 μM CHIR99021 (Stemgent) ...
-
bioRxiv - Microbiology 2020Quote: ... and 4,000 U/ml of rh IL-4 (R&D Systems) and cultured for 5 days ...
-
bioRxiv - Neuroscience 2022Quote: ... or IL-4 (20 ng/mL, 24 h, R&D Systems). Following stimulation ...
-
bioRxiv - Developmental Biology 2022Quote: ... BMP-4 (40 ng/ml, R&D Systems #5020-BP-010) or CHIR99021 (3 μM ...
-
bioRxiv - Cancer Biology 2022Quote: ... The caspase 4 inhibitor (Z-YVAD-FMK, FMK005, R&D systems) was used in further experiments at the dose of 50 µM ...
-
bioRxiv - Neuroscience 2023Quote: ... 4 µl of anti-V5-AF647 antibody (R&D Systems, FAB8926R) was used for staining cells for 20 minutes on a shaker at 500 rpm (Thermo Microplate Shaker) ...
-
bioRxiv - Molecular Biology 2023Quote: ... and growth factors: 5 ng/ml BMP-4 (R&D Systems), 9 ng/ml Activin A (R&D Systems) ...
-
bioRxiv - Bioengineering 2023Quote: ... and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days ...
-
bioRxiv - Microbiology 2024Quote: ... and IL-4 (R&D Systems, Cat# 6507-IL-025/CF) in complete RPMI ...
-
bioRxiv - Immunology 2024Quote: ... TNFα and IL-4 using ELISA kits from R&D Systems in accordance with the manufacturer’s instructions ...
-
bioRxiv - Molecular Biology 2021Quote: ... Additional reagents that were used are 2N Sulfuric Acid Stop Solution (Catalog no. DY994, R&D Systems, Minneapolis, MN), Triphenylphosphine (TPP ...
-
bioRxiv - Developmental Biology 2022Quote: ... day 5 lateral plate mesoderm or day 7 differentiating lung mesenchyme was transferred to cSFDM supplemented with 100 ng/ml rmVEGF (R&D Systems, # 493-MV-005). For evaluation of differentiation efficiency ...
-
bioRxiv - Cell Biology 2022Quote: Proteasome activity was assessed similarly by incubating cells with genetic (7 days) or chemical (1 hour) perturbations with Me4BoVS (R&D system; I-190-050). After incubation at 37ºC for 2 hours ...
-
bioRxiv - Bioengineering 2023Quote: ... Human mesenchymal stem cells (Passage 5-7) (commercially obtained from Rooster Bio (Frederick, MD)) were cultured in hMSC growth media (R&D Systems, Minneapolis, MN, USA). Adipose-derived stem cells (Passage 3-5 ...
-
bioRxiv - Immunology 2019Quote: ... with rat anti-mouse IL-18 (1 μg/ml; D047-3; R&D Systems), rabbit anti-human IL-18 (0.2 μg/ml ...
-
bioRxiv - Bioengineering 2021Quote: ... and Human chitinase 3-like 1 (YKL-40) were purchased from R&D Systems. Bovine serum albumin was purchased from Sigma Aldrich ...
-
bioRxiv - Microbiology 2021Quote: ... and Human IL29/IL28B (IFN-lambda 1/3) DuoSet ELISA (DY1598B, R&D Systems). Protein levels of IFNλ from intestinal biopsies were measured by Mouse IL28B/ IFN-lambda 3 DuoSet ELISA (DY1789B ...
-
bioRxiv - Cancer Biology 2022Quote: ... cocultures were treated with 3 μg/ml IL1α-neutralizing antibody (#MAB4001, R&D Systems) or isotype control antibody (#400902 ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
bioRxiv - Neuroscience 2021Quote: VEGF165b (3 – 30 ng; 5 µl; cat. #3045-VE-025, R&D System, USA), PlGF-2 (3 – 30 ng ...
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...